Perioperative acute kidney injury is common in infant heart surgery and portends a poor clinical outcome.

Background New intraparenchymal brain injury on MRI is observed in 36–73% of neonates after cardiac surgery with cardiopulmonary bypass (CPB). Brain immaturity in this population is common. We performed brain magnetic resonance imaging (MRI) before and after neonatal cardiac surgery, using a high flow CPB protocol, hypothesizing that MRI brain injury would be associated with brain immaturity. Methods CPB protocol included 150 ml/kg/min flows, pH stat management, hematocrit >30%, and high flow antegrade cerebral perfusion. Regional brain oxygen saturation (rSO2) was monitored, with a treatment protocol for rSO2 <50%. Brain MRI, consisting of T1, T2, and diffusion weighted imaging, and MR spectroscopy were performed preoperatively, 7 days postoperatively, and at age 3–6 months. Results Twenty-four of 67 patients (36%) had new postoperative white matter injury (WMI), infarction, or hemorrhage, and 16% had new WMI. Associations with preoperative brain injury included low brain maturity score (p=0.002). Postoperative WMI was associated with single ventricle (SV) diagnosis (p=0.02), preoperative WMI (p<0.001) and low brain maturity score (p=0.05). Low brain maturity score was also associated with more severe postoperative brain injury (p=0.01). Forty-five patients had a 3rd scan, with a 27% incidence of new minor lesions, but 58% of previous lesions had partially or completely resolved. Conclusions We observed a significant incidence of both pre- and postoperative MRI abnormality, and an association with brain immaturity. Many lesions resolved in the first 6 months after surgery. Timing of delivery and surgery with bypass could affect the risk of brain injury.

The ability to replace organs and tissues on demand could save or improve millions of lives each year globally and create public health benefits on par with curing cancer. Unmet needs for organ and tissue preservation place enormous logistical limitations on transplantation, regenerative medicine, drug discovery, and a variety of rapidly advancing areas spanning biomedicine. A growing coalition of researchers, clinicians, advocacy organizations, academic institutions, and other stakeholders has assembled to address the unmet need for preservation advances, outlining remaining challenges and identifying areas of underinvestment and untapped opportunities. Meanwhile, recent discoveries provide proofs of principle for breakthroughs in a family of research areas surrounding biopreservation. These developments indicate that a new paradigm, integrating multiple existing preservation approaches and new technologies that have flourished in the past 10 years, could transform preservation research. Capitalizing on these opportunities will require engagement across many research areas and stakeholder groups. A coordinated effort is needed to expedite preservation advances that can transform several areas of medicine and medical science.